Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Vizgen, Inc.

Vizgen, Inc.

Stage unknownWaltham, MAvizgen.comBiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Dec 29, 2025
    Form D equity offering · $47.8M (form d sold) · 9 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Vizgen, Inc. filed Form D: $47,788,714 sold of $50,000,000, Biotechnology”
Investors on record
1 edges
People
2 officers, 5 directors
Timeline
1
  1. Jan 12, 2026
    Vizgen, Inc. filed Form D: $47,788,714 sold of $50,000,000, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
16 observations
Every observation on this company